This is a routine director sale tied to equity compensation. The 1,556-share amount is negligible relative to the $17.5B market cap. No material signal for the stock. Monitor for any subsequent Form 4 filings to confirm execution, but this is not a red flag.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 23 $130.83entry
- T+1 · 5mo ago +4.69%α +4.73% · $136.96
- T+5 · 5mo ago +17.51%α +16.50% · $153.74
- T+20 · 4mo ago +13.18%α +12.02% · $148.07
- T+60 · 2mo ago +33.68%α +30.44% · $174.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Myrtle S. Potter, a Director of Guardant Health, filed a Form 144 on 2026-06-22 to sell 1,556 shares of common stock, with an estimated aggregate market value of approximately $204,085. The shares were acquired via a restricted stock lapse on 2026-06-18, indicating this is a routine equity-compensation-related sale.
Key Facts
- Insider: Myrtle S. Potter, a Director of Guardant Health
- Proposed sale: 1,556 shares of common stock
- Estimated value: ~$204,085 (based on $132.60/share reference price)
- Shares acquired on 2026-06-18 via restricted stock lapse (equity compensation)
- Form 144 filed on 2026-06-22, indicating intent to sell in the near future
- Sale represents a very small fraction of the company's $17.5B market cap
Financial Impact
~$204,085 (1,556 shares at ~$132.60/share)
Risk Factors
- No material risk, this is a standard insider sale for tax/compensation purposes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-000676 |
| Document: 0001921094-26-000676-index.html | 0001921094-26-000676 |
| Document: 0001921094-26-000676.txt | 0001921094-26-000676 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers